MXPA05006769A - El grupo genetico incluido en biosintesis de safracin y sus usos para ingenieria genetica. - Google Patents

El grupo genetico incluido en biosintesis de safracin y sus usos para ingenieria genetica.

Info

Publication number
MXPA05006769A
MXPA05006769A MXPA05006769A MXPA05006769A MXPA05006769A MX PA05006769 A MXPA05006769 A MX PA05006769A MX PA05006769 A MXPA05006769 A MX PA05006769A MX PA05006769 A MXPA05006769 A MX PA05006769A MX PA05006769 A MXPA05006769 A MX PA05006769A
Authority
MX
Mexico
Prior art keywords
gene cluster
genetic engineering
cluster involved
safracin
biosynthesis
Prior art date
Application number
MXPA05006769A
Other languages
English (en)
Inventor
Henriquez Pelaez Ruben
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MXPA05006769A publication Critical patent/MXPA05006769A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un grupo genetico tiene estructuras de lectura abierta que codifican los polipeptidos lo suficiente para dirigir la sintesis de una molecula de safracin.
MXPA05006769A 2002-12-20 2003-12-19 El grupo genetico incluido en biosintesis de safracin y sus usos para ingenieria genetica. MXPA05006769A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0229793.5A GB0229793D0 (en) 2002-12-20 2002-12-20 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
PCT/GB2003/005563 WO2004056998A1 (en) 2002-12-20 2003-12-19 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering

Publications (1)

Publication Number Publication Date
MXPA05006769A true MXPA05006769A (es) 2005-10-05

Family

ID=9950143

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006769A MXPA05006769A (es) 2002-12-20 2003-12-19 El grupo genetico incluido en biosintesis de safracin y sus usos para ingenieria genetica.

Country Status (13)

Country Link
US (1) US7723068B2 (es)
EP (1) EP1576159B9 (es)
JP (1) JP2006510375A (es)
CN (1) CN1753996A (es)
AT (1) ATE435289T1 (es)
AU (1) AU2003290288B8 (es)
CA (1) CA2510069A1 (es)
DE (1) DE60328222D1 (es)
ES (1) ES2329358T3 (es)
GB (1) GB0229793D0 (es)
MX (1) MXPA05006769A (es)
RU (1) RU2385935C2 (es)
WO (1) WO2004056998A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
US7955326B2 (en) 2006-12-29 2011-06-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Pressure-sensitive conductive composite electrode and method for ablation
WO2009138509A1 (en) * 2008-05-16 2009-11-19 Pharma Mar, S.A. Multiple myeloma treatments
AU2009246130A1 (en) * 2008-05-16 2009-11-19 Pharma Mar, S.A. Combination therapy with PM00 104 and another antitumor agent
US9487763B2 (en) * 2014-01-22 2016-11-08 Regents Of The University Of Michigan Nonribosomal peptide synthetases
US9994885B2 (en) * 2014-01-22 2018-06-12 Regents Of The University Of Michigan Nonribosomal peptide synthetases
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN114317581B (zh) * 2022-03-15 2022-06-24 中国科学院天津工业生物技术研究所 增强红色糖多孢菌的红霉素生产能力的方法及其获得的菌株

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6020000B2 (ja) * 1980-07-07 1985-05-18 ウェルファイド株式会社 新抗生物質ｙ−１６４８２物質およびその製造法
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
AR035842A1 (es) * 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo

Also Published As

Publication number Publication date
CN1753996A (zh) 2006-03-29
JP2006510375A (ja) 2006-03-30
EP1576159B1 (en) 2009-07-01
GB0229793D0 (en) 2003-01-29
EP1576159B9 (en) 2009-12-16
CA2510069A1 (en) 2004-07-08
RU2005122950A (ru) 2006-01-27
AU2003290288B8 (en) 2009-08-27
AU2003290288B2 (en) 2009-07-02
AU2003290288A1 (en) 2004-07-14
US7723068B2 (en) 2010-05-25
US20080182302A2 (en) 2008-07-31
ES2329358T3 (es) 2009-11-25
EP1576159A1 (en) 2005-09-21
DE60328222D1 (de) 2009-08-13
WO2004056998A1 (en) 2004-07-08
ATE435289T1 (de) 2009-07-15
RU2385935C2 (ru) 2010-04-10
US20060134764A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
MX2010001481A (es) Proteasas fungales acidas.
GB2355459B (en) A dominant conditional lethal genetic system
HK1152337A1 (zh) 同時表達硫酸酯酶和 -甲酰甘氨酸產生酶的細胞以及其方法及用途
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
NZ712789A (en) Placental stem cell populations
GB0305142D0 (en) Synthesis
TW200716753A (en) Vector
HK1084151A1 (en) Interleukin-18 mutants, their production and use
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
WO2005113774A3 (en) Methods for production of xylitol in microorganisms
MXPA05006769A (es) El grupo genetico incluido en biosintesis de safracin y sus usos para ingenieria genetica.
PH12014500829A1 (en) Mutations in oas1 genes
MXPA05002489A (es) Composiciones para el cuidado personal basadas en alcohol ramificado.
BRPI0418229A (pt) genes do ciclo celular e métodos corrrelatos de uso
DK1259593T3 (da) Tand-progenitorcelle og fremgangsmåde til frembringelse heraf
DE69433385D1 (de) Für die untereinheiten der 1,3-beta-d-glucansynthase kodierende dna
BR0313083A (pt) moléculas de adamts4 modificadas,polinucleotìdeo, vetor, processos para produção, composição farmacêutica, bem como uso das mesmas
IL177179A (en) Fusion protein comprising truncated n-acetylgalactosaminyltransferase 2 (galnact2) and maltose binding domain
ITRM20020115A0 (it) Espressione di enzimi lisosomiali in seme.
PL380665A1 (pl) Farmaceutyczne kompozycje
IL191782A0 (en) Method for generating dendritic cells employing decreased temperature
EP1945648A4 (en) DERIVATIVES OF 4,6-DISUBSTITUTED 1,2,4-TRIAZOLO-1,3,4-THIADIAZOL, A METHOD AND APPLICATIONS THEREOF
AU2003259750A1 (en) Methods and compositions for targeting secretory lysosomes
EA200601563A1 (ru) Водно-изопропанольный сольват оланзапина
MX2007005210A (es) Medio de cultivo de celula libre de suero para las celulas de los mamiferos.

Legal Events

Date Code Title Description
FG Grant or registration